We are live on
!
Find out more
MB
MPM BioImpact Portfolio holdings
AUM
$1.29B
1-Year Est. Return
141.72%
This Fund
S&P 500
This Quarter
Est. Return
+29.46%
1 Year Est. Return
+141.72%
3 Year Est. Return
+440.65%
5 Year Est. Return
+290.21%
10 Year Est. Return
–
AUM
$611M
AUM Growth
+$33.7M
(+5.8%)
Cap. Flow
-$56.3M
Cap. Flow
% of AUM
-9.22%
Top 10 Holdings %
Top 10 Hldgs %
48.78%
Holding
51
New
7
Increased
4
Reduced
2
Closed
11
Top Buys
| 1 |
Syndax Pharmaceuticals
SNDX
|
+$18M |
| 2 |
SLNO
Soleno Therapeutics
SLNO
|
+$7.41M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$6.74M |
| 4 |
Xenon Pharmaceuticals
XENE
|
+$6.34M |
| 5 |
Liquidia Corp
LQDA
|
+$4.34M |
Top Sells
| 1 |
Guardant Health
GH
|
+$23M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
+$14.8M |
| 3 |
MBX
MBX Biosciences
MBX
|
+$14.8M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
+$12.3M |
| 5 |
Olema Pharmaceuticals
OLMA
|
+$10.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Wave Life Sciences
WVE
$1.14B
| $11M | 1.8% |
1,505,262
| – | – |
|
|
DBVT
27
DBV Technologies
DBVT
$930M
| $10.5M | 1.73% |
1,054,504
| – | – |
|
|
SLNO
28
DELISTED
Soleno Therapeutics
SLNO
| $10.1M | 1.66% |
150,000
+100,000
| +200% | +$7.41M |
|
29
Solid Biosciences
SLDB
$947M
| $10.1M | 1.65% |
1,634,569
| – | – |
|
30
Akebia Therapeutics
AKBA
$370M
| $7.89M | 1.29% |
2,889,125
| – | – |
|
31
Werewolf Therapeutics
HOWL
$16.5M
| $4.75M | 0.78% |
2,408,810
| – | – |
|
|
32
Liquidia Corp
LQDA
$6.91B
| $4.55M | 0.74% |
+200,000
| New | +$4.34M |
|
|
PVLA
33
Palvella Therapeutics
PVLA
$2.18B
| $4.23M | 0.69% |
+67,423
| New | +$3.01M |
|
34
Design Therapeutics
DSGN
$844M
| $4.18M | 0.68% |
555,187
| – | – |
|
35
Cartesian Therapeutics
RNAC
$255M
| $3.88M | 0.64% |
380,000
-306,007
| -45% | -$3.44M |
|
36
enGene Therapeutics
ENGN
$127M
| $3.62M | 0.59% |
+530,299
| New | +$2.42M |
|
37
UroGen Pharma
URGN
$1.94B
| $2.69M | 0.44% |
+135,000
| New | +$2.42M |
|
|
RAPP
38
Rapport Therapeutics
RAPP
$1.91B
| $2.13M | 0.35% |
+71,807
| New | +$1.28M |
|
|
RPTX
39
DELISTED
Repare Therapeutics
RPTX
| $1.44M | 0.24% |
819,924
| – | – |
|
40
Assembly Biosciences
ASMB
$530M
| $1.02M | 0.17% |
+39,665
| New | +$870K |
|
|
ACLX
41
DELISTED
Arcellx
ACLX
| – | – |
-37
| Closed | -$2.44K |
|
|
ADAP
42
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-4,411,821
| Closed | -$1.06M |
|
|
43
Crinetics Pharmaceuticals
CRNX
$8.88B
| – | – |
-428,975
| Closed | -$12.3M |
|
|
44
Guardant Health
GH
$21.6B
| – | – |
-442,656
| Closed | -$23M |
|
|
45
MoonLake Immunotherapeutics
MLTX
$1.67B
| – | – |
-313,571
| Closed | -$14.8M |
|
46
Nuvation Bio
NUVB
$2.05B
| – | – |
-4,622,590
| Closed | -$9.01M |
|
|
47
Olema Pharmaceuticals
OLMA
$1.03B
| – | – |
-2,378,762
| Closed | -$10.1M |
|
48
Replimune Group
REPL
$813M
| – | – |
-983,780
| Closed | -$9.14M |
|
49
Taysha Gene Therapies
TSHA
$1.78B
| – | – |
-2,953,562
| Closed | -$6.82M |
|
50
Veru
VERU
$38.8M
| – | – |
-491,195
| Closed | -$2.86M |
|
Similar funds
MCM
PWP
ACM
GPCM
ACM
PCM
COCM
MA